BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9603406)

  • 1. Coagulation abnormalities and thrombotic microangiopathy following bone marrow transplantation from HLA-matched unrelated donors in patients with hematological malignancies.
    Natazuka T; Kajimoto K; Ogawa R; Imoto S; Koizumi T; Nishimura R; Nakagawa T
    Bone Marrow Transplant; 1998 Apr; 21(8):815-9. PubMed ID: 9603406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone marrow transplantation-associated thrombotic microangiopathy manifested by visual disturbance].
    Nakai K; Tajima K; Kishimoto Y; Katsura K; Kawamura M; Yamamoto Y; Hanada M; Zen K; Amakawa R; Fujimoto M; Fukuhara S
    Rinsho Ketsueki; 2000 Jan; 41(1):25-31. PubMed ID: 10695395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of haematopoietic stem cells derived from cord blood, bone marrow or peripheral blood: a single centre matched-pair analysis in a heterogeneous risk population.
    Schönberger S; Niehues T; Meisel R; Bernbeck B; Laws HJ; Kögler G; Enzmann J; Wernet P; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(6):356-63. PubMed ID: 15565551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matched unrelated donor marrow transplantation in patients with advanced acute leukemia.
    Greinix HT; Reiter E; Schulenburg A; Keil F; Lechner K; Fischer G; Rosenmayr A; Leitner G; Kalhs P
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S53-6. PubMed ID: 9916636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
    Kodera Y; Morishima Y; Kato S; Akiyama Y; Sao H; Matsuyama T; Kawa K; Sakamaki H; Nakagawa S; Hirabayashi N; Dohi H; Okamoto S; Hiraoka A; Gondo H; Tsuchida M; O H; Harada M; Asano S; Juji T; Sasazuki T; Takaku F
    Bone Marrow Transplant; 1999 Nov; 24(9):995-1003. PubMed ID: 10556959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A survey of use of unrelated volunteer donor bone marrow transplantation at 46 centres worldwide, 1989-93. International Marrow Unrelated Search and Transplant (IMUST) Study.
    Downie TR; Hows JM; Gore SM; Bradley BA; Howard MR
    Bone Marrow Transplant; 1995 Apr; 15(4):499-503. PubMed ID: 7655372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apheresis in grade 4 bone marrow transplant associated thrombotic microangiopathy: a case series.
    Dua A; Zeigler ZR; Shadduck RK; Nath R; Andrews DF; Agha M
    J Clin Apher; 1996; 11(4):176-84. PubMed ID: 8986863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable outcomes of HLA-matched unrelated and HLA-identical sibling donor bone marrow transplantation for childhood acute myeloid leukemia in first remission.
    Lee DH; Kwon YJ; Lim J; Kim Y; Han K; Chung NG; Jeong DC; Cho B; Kim HK
    Pediatr Transplant; 2009 Mar; 13(2):210-6. PubMed ID: 18627512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic microangiopathy following allogeneic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis.
    Paquette RL; Tran L; Landaw EM
    Bone Marrow Transplant; 1998 Aug; 22(4):351-7. PubMed ID: 9722070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT).
    Corvò R; Lamparelli T; Bruno B; Barra S; Van Lint MT; Vitale V; Bacigalupo A
    Bone Marrow Transplant; 2002 Dec; 30(11):717-23. PubMed ID: 12439693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
    Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
    Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplant-associated thrombotic microangiopathy: a case series.
    Zeigler ZR; Shadduck RK; Nemunaitis J; Andrews DF; Rosenfeld CS
    Bone Marrow Transplant; 1995 Feb; 15(2):247-53. PubMed ID: 7773214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
    Chim CS; Lie AK; Liang R; Au WY; Kwong YL
    Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathy following allogeneic bone marrow transplantation.
    Takatsuka H; Takemoto Y; Okamoto T; Fujimori Y; Tamura S; Wada H; Okada M; Kanamaru A; Kakishita E
    Bone Marrow Transplant; 1999 Aug; 24(3):303-6. PubMed ID: 10455370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unrelated donor marrow transplantation in childhood: a report from the Associazione Italiana Ematologia e Oncologia Pediatrica (AIEOP) and the Gruppo Italiano per il Trapianto Midollo Osseo (GITMO).
    Dini G; Cancedda R; Giorgiani G; Porta F; Messina C; Uderzo C; Pession A; Fagioli F; La Nasa G; Arcese W; Pollichieni S; Zecca M; Lanino E; Mazzolari E; Cesaro S; Balduzzi A; Rondelli R; Vassallo E; Cappelli B; Locatelli F;
    Haematologica; 2002 Aug; 87(8 Suppl):51-7. PubMed ID: 12412391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercoagulability in patients undergoing autologous or allogeneic BMT for hematological malignancies.
    Catani L; Gugliotta L; Mattioli Belmonte M; Vianelli N; Gherlinzoni F; Miggiano MC; Belardinelli AR; Rosti G; Calori E; Bandini G
    Bone Marrow Transplant; 1993 Sep; 12(3):253-9. PubMed ID: 8241985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early hemostatic alterations following bone marrow transplantation: a prospective study.
    Vannucchi AM; Rafanelli D; Longo G; Bosi A; Guidi S; Saccardi R; Filimberti E; Cinotti S; Grossi A; Morfini M
    Haematologica; 1994; 79(6):519-25. PubMed ID: 7896209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor/recipient mixed chimerism does not predict graft failure in children with beta-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling.
    Lisini D; Zecca M; Giorgiani G; Montagna D; Cristantielli R; Labirio M; Grignani P; Previderè C; Di Cesare-Merlone A; Amendola G; Bergami E; Mastronuzzi A; Maccario R; Locatelli F
    Haematologica; 2008 Dec; 93(12):1859-67. PubMed ID: 18945748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes.
    Roy V; Rizvi MA; Vesely SK; George JN
    Bone Marrow Transplant; 2001 Mar; 27(6):641-6. PubMed ID: 11319595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.